Across TCGA pan-cancer cohorts, GRPEL2P2 RNA differs between tumor and matched normal tissue in 3 of 18 cancer types tested, making tumor–normal expression one of GRPEL2P2’s most consistent transcriptional readouts.

The strongest signal is observed in breast invasive carcinoma (BRCA), where GRPEL2P2 RNA is repressed in tumor relative to normal tissue. In most cancer types GRPEL2P2 is over-expressed in tumor, although a few such as BRCA and STAD show the opposite, repressed pattern.

BRCA, COAD, and STAD are the cancer types where GRPEL2P2 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in GRPEL2P2 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
BRCA	All	All	−0.010	.012	4	view →
COAD	All	II,III,IV	+0.042	.028	2	view →
STAD	All	All	−0.066	.046	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 3 strongest of 3 lineages.

Exploration

Same gene, other analysis: GRPEL2P2 RNA expression & survival · all GRPEL2P2 data types